APA (7th ed.) Citation

Lambru, G., Hill, B., Murphy, M., Tylova, I., & Andreou, A. P. (2020). A prospective real-world analysis of erenumab in refractory chronic migraine. Journal of headache and pain, 21(1), 61-10. https://doi.org/10.1186/s10194-020-01127-0

Chicago Style (17th ed.) Citation

Lambru, Giorgio, Bethany Hill, Madeleine Murphy, Ivona Tylova, and Anna P. Andreou. "A Prospective Real-world Analysis of Erenumab in Refractory Chronic Migraine." Journal of Headache and Pain 21, no. 1 (2020): 61-10. https://doi.org/10.1186/s10194-020-01127-0.

MLA (9th ed.) Citation

Lambru, Giorgio, et al. "A Prospective Real-world Analysis of Erenumab in Refractory Chronic Migraine." Journal of Headache and Pain, vol. 21, no. 1, 2020, pp. 61-10, https://doi.org/10.1186/s10194-020-01127-0.